“Maximum strength” claims on over-the-counter pain relief patches don’t literally mean the highest dose of medication money can buy, a federal judge said in dismissing, for now, a false-ad suit against
Steven Prescott filed a proposed class suit in the US District Court for the Northern District of New York, alleging that the labeling of “Maximum Strength Pain Relief Lidocaine Patches” with 4% lidocaine is deceptive because a consumer could get a doctor’s prescription for a 5% lidocaine patch.
Other courts have allowed similar claims to advance against other companies, but Judge Vince Chhabria said a reasonable ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.